1996
An International Collaborative Study of the Effects of Coinfection with Human T-Lymphotropic Virus Type II on Human Immunodeficiency Virus Type 1 Disease Progression in Injection Drug Users
Hershow R, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, Klein R, Jarlais D, Vitek C, Khabbaz R, Freels S, Zuckerman R, Pezzotti P, Kaplan J. An International Collaborative Study of the Effects of Coinfection with Human T-Lymphotropic Virus Type II on Human Immunodeficiency Virus Type 1 Disease Progression in Injection Drug Users. The Journal Of Infectious Diseases 1996, 174: 309-317. PMID: 8699060, DOI: 10.1093/infdis/174.2.309.Peer-Reviewed Original ResearchConceptsInjection drug usersCD4 cell percentCell percentHuman immunodeficiency virus type 1 (HIV-1) disease progressionHuman immunodeficiency virus type 1 (HIV-1) infectionDrug usersInfected injection drug usersVirus type 1 infectionHuman T-lymphotropic virus type IIHIV seroconversion datesHTLV-II infectionType 1 infectionProportional hazards modelEffect of coinfectionSeroconversion datesCohort studyHIV infectionHTLV infectionDisease progressionAIDS mortalityHTLV-IIHazards modelRate of declineInternational collaborative studyWestern blot
1994
Impact of HIV infection on non-AIDS mortality among Italian injecting drug users
Zaccarelli M, Gattari P, Rezza G, Conti S, Spizzichino L, Vlahov D, Ippolito G, Lelli V, Valenzi C. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS 1994, 8: 345-350. PMID: 8031512, DOI: 10.1097/00002030-199403000-00008.Peer-Reviewed Original ResearchConceptsHIV seropositivesHIV serostatusAIDS mortalityMortality rateAge-adjusted standardized mortality ratiosDrug usersHIV-negative IDUsHIV-seronegative IDUsHIV-seropositive IDUPerson-time techniquesStandardized mortality ratioCause-specific mortalityDrug treatment centersRate of deathHIV-seronegativesPossible HIVHIV infectionHIV testingProspective studyMortality ratioExcess mortalityGeneral populationOverdose mortalityAIDS causesHIV